Picture of Demant A/S logo

DEMANT — Demant A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Barclays prefers Sonova as European hearing-aid recovery continues

BUZZ-Barclays prefers Sonova as European hearing-aid recovery continues

** Barclays said its latest US audiologist survey points to improving sentiment and a continued recovery in the hearing-aid market

** "Market recovery expected to persist although we see this as increasingly in the price and remain selective," the broker says

** It upgrades Swiss hearing-aid maker Sonova SOON.S to "overweight" from "underweight", expecting around 200 basis points of market-share gains and citing strong differentiation from its Phonak EON launch

** It downgrades GN Store Nord GN.CO to "equal weight" from "overweight", saying much of the recovery story is already reflected in the shares after a 32% rally over the last three months

** Barclays keeps Demant DEMANT.CO and Amplifon AMPF.MI at "equal weight", citing expected market-share losses for Demant and execution risks linked to Amplifon's integration of GN Hearing ** Including the session's moves, Sonova shares are up about 41% YTD, Demant is up 60%, GN up 9% and Amplifon down 17%


(Reporting by Kira Britten)

((Kira.Britten@thomsonreuters.com))

Recent news on Demant A/S

See all news